|
06/30/2020* |
Transamerica Janus Mid-Cap Growth VP
| Security Description | % of Total Net Assets |
|---|---|
| Constellation Software, Inc. | 3.44% |
| Microchip Technology, Inc. | 2.68% |
| Nice, Ltd., ADR | 2.66% |
| Aon PLC, Class A | 2.31% |
| SS&C Technologies Holdings, Inc. | 2.29% |
| LPL Financial Holdings, Inc. | 2.25% |
| WEX, Inc. | 2.13% |
| Global Payments, Inc. | 2.13% |
| PerkinElmer, Inc. | 2.10% |
| Broadridge Financial Solutions, Inc. | 2.04% |
| GoDaddy, Inc., Class A | 1.94% |
| KLA Corp. | 1.94% |
| Fidelity National Information Services, Inc. | 1.91% |
| Boston Scientific Corp. | 1.89% |
| Crown Castle International Corp., REIT | 1.89% |
| Sensata Technologies Holding PLC | 1.85% |
| TE Connectivity, Ltd. | 1.83% |
| Verisk Analytics, Inc. | 1.77% |
| Cooper Cos., Inc. | 1.75% |
| Intact Financial Corp. | 1.69% |
| Lamar Advertising Co., Class A, REIT | 1.69% |
| STERIS PLC | 1.67% |
| Lam Research Corp. | 1.60% |
| Amdocs, Ltd. | 1.58% |
| W.R. Berkley Corp. | 1.56% |
| Atlassian Corp. PLC, Class A | 1.56% |
| Catalent, Inc. | 1.54% |
| ON Semiconductor Corp. | 1.54% |
| CarMax, Inc. | 1.46% |
| IQVIA Holdings, Inc. | 1.44% |
| CoStar Group, Inc. | 1.40% |
| L3 Harris Technologies, Inc. | 1.39% |
| Wayfair, Inc., Class A | 1.39% |
| Teledyne Technologies, Inc. | 1.29% |
| National Instruments Corp. | 1.28% |
| Dunkin' Brands Group, Inc. | 1.25% |
| Willis Towers Watson PLC | 1.17% |
| Ritchie Bros Auctioneers, Inc. | 1.15% |
| Sealed Air Corp. | 1.14% |
| Dolby Laboratories, Inc., Class A | 1.10% |
| Xilinx, Inc. | 1.02% |
| Waters Corp. | 1.00% |
| Teleflex, Inc. | 0.99% |
| Westinghouse Air Brake Technologies Corp. | 0.95% |
| Cimpress PLC | 0.92% |
| ServiceMaster Global Holdings, Inc. | 0.91% |
| Flex, Ltd. | 0.89% |
| Rexnord Corp. | 0.89% |
| IHS Markit, Ltd. | 0.86% |
| Edenred | 0.77% |
| Ceridian HCM Holding, Inc. | 0.77% |
| PRA Health Sciences, Inc. | 0.72% |
| DENTSPLY SIRONA, Inc. | 0.70% |
| Ingersoll Rand, Inc. | 0.69% |
| Royalty Pharma PLC, Class A | 0.69% |
| Gildan Activewear, Inc. | 0.68% |
| Ryanair Holdings PLC, ADR | 0.67% |
| Ferguson PLC | 0.67% |
| ICU Medical, Inc. | 0.64% |
| Sarepta Therapeutics, Inc. | 0.64% |
| Elanco Animal Health, Inc. | 0.63% |
| Varian Medical Systems, Inc. | 0.63% |
| Alliant Energy Corp. | 0.63% |
| Cboe Global Markets, Inc. | 0.62% |
| Bristol-Myers Squibb Co. | 0.59% |
| MSCI, Inc. | 0.58% |
| TD Ameritrade Holding Corp. | 0.57% |
| frontdoor, Inc. | 0.56% |
| SVB Financial Group | 0.55% |
| Aramark | 0.54% |
| Neurocrine Biosciences, Inc. | 0.53% |
| Carlisle Cos., Inc. | 0.52% |
| Middleby Corp. | 0.49% |
| Liberty Media Corp. - Liberty Formula One, Class C | 0.47% |
| Euronet Worldwide, Inc. | 0.43% |
| Visteon Corp. | 0.43% |
| Dynatrace, Inc. | 0.42% |
| Ascendis Pharma A/S, ADR | 0.25% |
| Net Other Assets (Liabilities) | 3.80% |
Mutual funds, variable annuities and variable life insurance policies are subject to market risk, including the loss of principal. There is no assurance the fund will meet its investment objective. See the fund’s prospectus for complete information on all of the risks inherent with investing in the fund.
*There is no assurance that the securities listed are held beyond the indicated date. The holdings will remain online for six months, starting 15 days after the end of each calendar month.
**This security represents less than 0.01% of total holdings.
The Net Other Assets (Liabilities) category may include, but is not limited to, repurchase agreements, reverse repurchase agreements, security lending collateral, forward foreign currency contracts, and cash collateral.
This list of portfolio holdings is published on a delayed basis, 15 days after the end of each calendar month, and does not necessarily represent the actual investments held by a portfolio at the time of publication. All holdings are subject to change daily. This list has not been audited and is provided for informational use only. It is not intended as a recommendation, offer, or solicitation for the purchase or sale of any security. Transamerica assumes no obligation to update or supplement this list to reflect any change that may occur, and assumes no liability relating to the use of this information.
Unlike the fund’s regulatory filings, the portfolio data and its presentation in this document are not required to conform to Generally Accepted Accounting Principles (GAAP) and Securities and Exchange Commission (SEC) presentation requirements. Therefore, it differs from that in the complete statement of investments in the annual and semiannual report to shareholders filed with the SEC on Form N-CSR, and the complete statement of investments provided in the first and third quarter SEC Form N-Q filings for each fiscal year.
Shares of the funds may only be sold by offering the funds’ prospectus. You should consider the investment objective, risks, charges, and expenses of the fund carefully before investing. The prospectus contains this and additional important information regarding the fund. For Transamerica Funds - To obtain the prospectus and/or a summary prospectus, please contact your financial professional or go to transamerica.com. For Transamerica Partners Funds - go to transamericapartners.com. For Transamerica Series Trust portfolios - Investors should carefully consider their investment objectives and risks, along with a product’s charges and expenses before investing. The prospectus includes complete information and other important facts about the variable annuity or variable universal life insurance policy’s charges and expenses. Please contact your financial professional for a prospectus. The prospectus should be read carefully before investing.
Transamerica Series Trust portfolios are only available through the purchase of a variable life insurance policy or variable annuity contract.
No part of this material may be reproduced in any form, or referred to in any publication, without express written permission.
TAHLD-WB0417